Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia-Reference-Cited by-同舟云学术

Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia

Published:2022-02-22 Issue:2 Volume:2 Page:
ISSN:2754-3242
Container-title:Medicine International
language:
Short-container-title:Med Int

Author:

Martínez‑López Joaquín¹,Montesinos Pau²,López‑Muñoz Nieves³,Ayala Rosa³,Martínez‑Sánchez Pilar³,Gorrochategui Julian⁴,Rojas‑Rudilla José⁴,Primo Daniel⁵,Bergua‑Burgues Juan-Miguel⁶,Calbacho María³,Acuña‑Cruz Evelyn²,Pérez‑Simón José⁷,De La Fuente Adolfo⁸,Pérez De Oteyza Jaime⁹,Rodriguez‑Veiga Rebeca²,Pina José³,Boluda Blanca²,Cano Isabel²,Paciello Coronel María³,Ballesteros Juan¹⁰

Affiliation:

1. Department of Hematology, 12 de Octubre Hospital, Instituto de Investigación Hospital 12 de Octubre (i+12), Complutense University, H12O‑CNIO Clinical Research Unit, CIBERONC, 28041 Madrid, Spain

2. Department of Hematology and Hemotherapy, La Fe University and Polytechnic Hospital, 46026 Valencia, Spain

3. Department of Hematology, 12 de Octubre Hospital, 28041 Madrid, Spain

4. Bioinformatics, Vivia Biotech, 28760 Madrid, Spain

5. VP Science, Vivia Biotech, 28760 Madrid, Spain

6. Department of Hematology, San Pedro de Alcántara Hospital, 10003 Cáceres, Spain

7. Department of Hematology, Virgen del Rocio University Hospital, Institute of Biomedicine of Sevilla (IBIS/CSIC, CIBERONC), University of Sevilla, 41013 Sevilla, Spain

8. Department of Hematology, MD Anderson Cancer Center, 28033 Madrid, Spain

9. Department of Hematology, HM Sanchinarro University Hospital, School of Medicine, University CEU San Pablo, 28050 Madrid, Spain

10. 0CSO, Vivia Biotech, 28760 Madrid, Spain

Publisher

Spandidos Publications

Subject

General Medicine

Reference39 articles.

1. Acute myeloid leukemia;Dohner;N Engl J Med,2015

2. Prognostic factors in acute myeloid leukaemia;Löwenberg;Best Pract Res Clin Haematol,2001

3. The difficult problem of acute myeloid leukemia in the older adult;Stone;CA Cancer J Clin,2002

4. Advances in non-intensive chemotherapy treatment options for adults diagnosed with acute myeloid leukemia;Griffiths;Leuk Res,2020

5. Acute myeloid leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up;Heuser;Ann Oncol,2020